Literature DB >> 2981937

Cytomegalovirus infection in sex partners: evidence for sexual transmission.

H H Handsfield, S H Chandler, V A Caine, J D Meyers, L Corey, E Medeiros, J K McDougall.   

Abstract

To examine the hypothesis that cytomegalovirus (CMV) is sexually transmitted, we determined the prevalences of antibody to CMV and viral shedding in 63 male sex partners of women with or without CMV infection, and CMV isolates from infected couples were compared by DNA restriction enzyme analysis. The prevalence of seropositivity by enzyme-linked immunosorbent assay was 31 (74%) of 42 men whose female partners were seropositive compared with five (31%) of 16 men whose partners were seronegative (P = .008). CMV was isolated from the semen or urine of four (22%) of 18 men whose female partners shed CMV from the cervix or urine compared with none of 42 whose partners were culture negative (P = .013). DNA restriction enzyme typing of CMV isolates from three pairs of sex partners showed that two of the couples were infected with common strains; epidemiologically unrelated isolates gave distinct patterns. Heterosexual contact is a major mode of transmission of CMV among some young adults.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981937     DOI: 10.1093/infdis/151.2.344

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Natural Inhibitor of Human Cytomegalovirus in Human Seminal Plasma.

Authors:  Sina Lippold; Berenike Braun; Franziska Krüger; Mirja Harms; Janis A Müller; Rüdiger Groß; Jan Münch; Jens von Einem
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Sexually transmitted disease in potential semen donors.

Authors:  E F Monteiro; R C Spencer; G R Kinghorn; C L Barratt; S Cooke; I D Cooke
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

3.  Elimination of toxicity and enhanced cytomegalovirus detection in cell cultures inoculated with semen from patients with acquired immunodeficiency syndrome.

Authors:  C L Howell; M J Miller; D A Bruckner
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

4.  Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.

Authors:  William J Britt
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

5.  Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences.

Authors:  Hiroshi Nakase; Hans Herfarth
Journal:  Inflamm Intest Dis       Date:  2016-01-23

6.  Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan.

Authors:  Hamdan Z Hamdan; Ismail E Abdelbagi; Nasser M Nasser; Ishag Adam
Journal:  Virol J       Date:  2011-05-11       Impact factor: 4.099

Review 7.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

8.  Molecular cloning of DNA sequences from cervical intraepithelial neoplasia that hybridize to human cytomegalovirus DNA.

Authors:  K Fletcher; J C Macnab
Journal:  Virus Genes       Date:  1989-08       Impact factor: 2.332

9.  Cytomegalovirus Kinetics Following Primary Infection in Healthy Women.

Authors:  Michael S Forman; Dhananjay Vaidya; Oluwaseyi Bolorunduro; Marie Diener-West; Robert F Pass; Ravit Arav-Boger
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

10.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.